Thats a good point, worse comes to worse these guys who actually understand the science and value behind MANF could possibly help fund the AMBS machine. Makes me wonder then why they haven't already done so? I mean Dr. Rubenfeld has said this could be the biggest success he's ever seen right? Why wouldn't he want a nice piece of the pie and invest $2-3 million into it instead of being paid as an advisor? Either way, each day we move closer to one or more IND applications for MANF as an Orphan drug. Only 6 weeks left in the 3rd quarter, LYMPRO results will make or break the pps for the time being.
News 
Market Data 
Discover 
